These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 19750489)

  • 1. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach.
    Vergote V; Burvenich C; Van de Wiele C; De Spiegeleer B
    J Pept Sci; 2009 Nov; 15(11):697-710. PubMed ID: 19750489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and international harmonization of pharmacopoeial standards.
    Calam DH
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role and functions of the International Pharmacopoeia.
    Wieniawski W
    Ann Ist Super Sanita; 1975; 11(3-4):204-10. PubMed ID: 1234722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ICH4 and pharmacopoeias: similarities and differences].
    Artiges A
    Ann Pharm Fr; 1999 Mar; 57(2):161-7. PubMed ID: 10365473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the pharmacopoeia in the control of pharmaceutical preparations.
    Grainger HS
    Ann Ist Super Sanita; 1975; 11(3-4):305-13. PubMed ID: 1234732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between sales authorisation and pharmacopoeia.
    Cook D
    Ann Ist Super Sanita; 1975; 11(3-4):281-9. PubMed ID: 1234729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects.
    Rastogi S; Shukla S; Kalaivani M; Singh GN
    Drug Discov Today; 2019 Jan; 24(1):148-162. PubMed ID: 30296551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
    Williams RL; ;
    J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of analytical quality specifications for biomarker assays currently used in acute cardiac care.
    Panteghini M
    Acute Card Care; 2006; 8(3):133-8. PubMed ID: 17012126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.